Comunicati Stampa
Salute e Benessere

Navamedic ASA - Investor presentation regarding the acquisition of the business of dne pharma AS

For further information, please contact: For further information, please contact: Kathrine Gamborg Andreassen, CEO, Mobile: +47 951 78 880 E-mail:kathrine@navamedic.comLars Hjarrand, CFO, Mobile: +47 917 62 842 E-mail:Lars.Hjarrand@navamedic.com About Navamedic Navamedic ASA is a full-service provider of high-quality healthcare products to hospitals and pharmacies. Navamedic meets the specific medical needs of patients and consumers by leveraging its highly scalable market...
OSLO, Norway, (informazione.news - comunicati stampa - salute e benessere)

For further information, please contact:

Kathrine Gamborg Andreassen , CEO, Mobile: +47 951 78 880 E-mail: kathrine@navamedic.com
Lars Hjarrand, CFO, Mobile: +47 917 62 842 E-mail: Lars.Hjarrand@navamedic.com

About Navamedic

Navamedic ASA is a full-service provider of high-quality healthcare products to hospitals and pharmacies. Navamedic meets the specific medical needs of patients and consumers by leveraging its highly scalable market access platform, leading category competence and local knowledge. Navamedic is present in all the Nordic countries, the Baltics and Benelux, with sales representation in Greece . Navamedic is headquartered in Oslo, Norway , and listed on the Oslo Stock Exchange (OSE: NAVA). For more information, please visit www.navamedic.com.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/navamedic-asa/r/navamedic-asa---investor-presentation-regarding-the-acquisition-of-the-business-of-dne-pharma-as,c4167735

The following files are available for download:

 

View original content:https://www.prnewswire.co.uk/news-releases/navamedic-asa--investor-presentation-regarding-the-acquisition-of-the-business-of-dne-pharma-as-302489311.html

Ufficio Stampa
 PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom
Allegati
Non disponibili